Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Magic Mushrooms

<< Previous

Bullboard Posts

Next >>

Comment by jeffm34on Apr 26, 2021 1:23pm

106 Views

Post# 33067492

RE:RE:RE:RE:RE:RE:Magic Mushrooms

I think you have nailed the main problem. It's a closed minded business culture of "only we know best". They would rather fail miserably with their own ideas than admit they might benefit from outside advice or help. No one is held responsible for any mistakes.

Bucknelly21 wrote: This just confirms what we all have been saying. They are either stupid (which I don't believe) or stubborn and don't want to admit that they are wrong in their approach to just about everything

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!